Abstract
Candida nivariensis is a new emergent agent related to human infections in the vaginal tract and other localizations, but the phenotypic characteristics are very similar to Candida glabrata and can be misidentified and underdiagnosed. We described four cases of vulvovaginitis identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and confirmed the results with PCR amplification and sequencing of the entire ITS genomic region (ITS1, ITS2 and 5.8 rRNA). We reinforce the need for new diagnostic tools for the correct identification of yeast infections.
References
Alcoba-Flórez J, Méndez-Alvarez S, Cano J, Guarro J, Pérez-Roth E, Arévalo MP. Phenotypic and molecular characterization of Candida nivariensis sp.nov., a possible new opportunistic fungus. J Clin Microbiol. 2005;43:4107–11.
Borman AM, Petch R, Linton CJ, Palmer MD, Bridge PD, Johnson EM. Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents. J Clin Microbiol. 2008;46:933–8.
Bishop JA, Chase N, Lee R, Kurtzman CP, Merz WG. Production of white colonies on CHROMagar Candida medium by members of the Candida glabrata clade and other species with overlapping phenotypic traits. J Clin Microbiol. 2008;46:3498–500.
Marklein G, Josten M, Klanke U, Muller E, Horre R, et al. Matrix-assisted laser desorption ionization time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J Clin Microbiol. 2009;47:2912–7.
Stevenson L, Drake S, Shea Y, Zelazny A, Murray P. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinically important yeast species. J Clin Microbiol. 2010;48:3482–6.
Pinto A, Halliday C, Zahra M, van Hal S, Olma T, Maszewska K, et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry identification of yeasts is contingent on robust reference spectra. PLoS One. 2011;6:e2571.
Gorton RL, Jones GL, Kibbler CC, Collier S. Candida nivariensis isolated from a renal transplant patient with persistent candiduria. Molecular identification using ITS PCR and MALDI-TOF. Med Mycol Case Rep. 2013;2:156–8.
Ghosh AK, Paul S, Sood P, Rudramurthy SM, Rajbanshi A, Jillwin TJ, et al. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for the rapid identification of yeasts causing bloodstream infections. Clin Microbiol Infect. 2015;21:372–8.
Cornet M, Sendid B, Fradin C, Gaillardin C, Poulain D, Nguyen HV. Molecular identification of closely related Candida species using two ribosomal intergenic spacer fingerprinting methods. J Mol Diagn. 2011;13:12–22.
Alcoba-Florez J, del Pilar Arévalo M, González-Paredes FJ, Cano J, Guarro J, et al. PCR protocol for specific identification of Candida nivariensis, a recently described pathogenic yeast. J Clin Microbiol. 2005;43:6194–6.
Galán-Sánchez F, García-Agudo L, García-Martos P, Rodríguez-Iglesias M. Candida galli as a cause of tinea unguium-molecular characterization of a rare clinical fungal entity. Mycopathologia. 2014;178:303–6.
Fujita S, Senda Y, Okusi T, Ota Y, Takada H, Yamada K, et al. Catheter-related fungemia due to fluconazole-resistant Candida nivariensis. J Clin Microbiol. 2007;45:3459–61.
Wahyuningsih R, SahBandar IN, Theelen B, Hagen F, et al. Candida nivariensis isolated from an indonesian human immunodeficiency virus-infected patient suffering from oropharyngeal candidiasis. J Clin Microbiol. 2008;46:388–91.
Lockhart SR, Messer SA, Gherna M, Bishop JA, Merz WG, et al. Identification of Candida nivariensis and Candida bracariensis in a large global collection of Candida glabrata isolates: comparison to literature. J Clin Microbiol. 2008;47:1216–7.
Chowdhary A, Randhawa HS, Khan ZU, Ahmad S, Juneja S, Sharma B, et al. First isolations in India of Candida nivariensis, a globally emerging opportunistic pathogen. Med Micol. 2010;48:416–20.
López-Soria LM, Bereciartua E, Santamaría M, Soria LM, Hernández-Almaraz JL, Mularoni A, et al. First case report of catheter-related fungemia by Candida nivariensis in the Iberian Peninsula. Rev Iberoam Micol. 2013;30:69–71.
Sharma C, Wankhede S, Muralidhar S, Prakash A, Singh PK, Kathuria S, et al. Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi. India. Diagn Microbiol Infect Dis. 2013;76:46–50.
Parmeland L, Gazon M, Guerin C, Argaud L, Lehot JJ, Bastien O, et al. Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade. Med Mycol. 2013;51:33–7.
Tay ST, Lotfalikhani A, Sabet NS, Ponnampalavanar S, Sulaiman S, Na SL, et al. Occurrence and characterization of Candida nivariensis from a culture collection of Candida glabrata clinical isolates in Malaysia. Mycopathologia. 2014;178:307–14.
Swoboda-Kopec E, Sikora M, Golas M, Piskorska K, Gozdowski D, Netsvyetayeva I. Candida nivariensis in comparison to different phenotypes of Candida glabrata. Mycoses. 2014;57:747–53.
Li J, Shan Y, Fan S, Liu X. Prevalence of Candida nivariensis and Candida bracarensis in vulvovaginal candidiasis. Mycopathologia. 2014;178:279–83.
Feng X, Ling B, Yang X, Liao W, Pan W, Yao Z. Molecular identification of Candida species isolated from onychomycosis in Shanghai, China. Mycopathologia. 2015;. doi:10.1007/s11046-015-9927-9.
Gabaldon T, Martin T, Marcet-Houben M, Durrens P, Bolotin-Fukuhara M, Lespinet O, et al. Comparative genomics of emerging pathogens in the Candida glabrata clade. BMC Genom. 2013;14:623.
Fraser M, Borman AM, Johnson EM. Evaluation of the commercial rapid trehalose test (GLABRATA RTT) for the point of isolation identification of Candida glabrata isolates in primary cultures. Mycopathologia. 2012;173:259–64.
Borman AM, Petch R, Linton CJ, Palmer MD, Bridge PD, Johnson EM. Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents. J Clin Microbiol. 2008;46:933–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aznar-Marin, P., Galan-Sanchez, F., Marin-Casanova, P. et al. Candida nivariensis as a New Emergent Agent of Vulvovaginal Candidiasis: Description of Cases and Review of Published Studies. Mycopathologia 181, 445–449 (2016). https://doi.org/10.1007/s11046-015-9978-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-015-9978-y